CFA
LLY icon

Compass Financial Advisors’s Eli Lilly LLY Stock Holding History

Compass Financial Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,898
Closed -$652K – 52
2023
Q1 		$652K Sell
1,898
-238
-11% -$80.3K 0.83% 40
2022
Q4 		$781K Sell
2,136
-44
-2% -$15.6K 1.05% 30
2022
Q3 		$705K Sell
2,180
-11
-0.5% -$3.48K 1.05% 28
2022
Q2 		$710K Sell
2,191
-190
-8% -$57K 0.97% 34
2022
Q1 		$682K Hold
2,381
– – 0.75% 44
2021
Q4 		$658K Buy
+2,381
New +$604K 0.72% 50

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Compass Financial Advisors's LLY Position: Q2 2023 in Review

Compass Financial Advisors sold out of Eli Lilly (LLY) in Q2 2023, closing a stake of 1,898 shares — an estimated $652K sold.

Compass Financial Advisors first reported a position in LLY in Q4 2021 and held it in 6 quarters. The position peaked at $781K in Q4 2022. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Compass Financial Advisors reported no remaining Eli Lilly position as of Q2 2023 after selling out during the quarter.
  • Compass Financial Advisors sold 1,898 Eli Lilly shares in Q2 2023, an estimated $652K.
  • Compass Financial Advisors first reported a position in Eli Lilly in Q4 2021 and held it in 6 quarters.
  • Compass Financial Advisors's Eli Lilly position peaked at $781K in Q4 2022.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Compass Financial Advisors's 13F filing for Q2 2023.